Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia

被引:147
作者
Martin, DA
Zheng, LX
Siegel, RM
Huang, BH
Fisher, GH
Wang, J
Jackson, CE
Puck, JM
Dale, J
Straus, SE
Peter, ME
Krammer, PH
Fesik, S
Lenardo, MJ
机构
[1] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Clin Invest Lab, NIH, Bethesda, MD 20892 USA
[3] Natl Human Genome Res Inst, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA
[4] Howard Hughes Med Inst, Natl Inst Hlth, Res Scholars Program, D-69120 Heidelberg, Germany
[5] German Canc Res Ctr, D-69120 Heidelberg, Germany
[6] Abbott Labs, Abbott Pk, IL 60064 USA
关键词
D O I
10.1073/pnas.96.8.4552
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Heterozygous mutations in the CD95 (APO-1/Fas) receptor occur in most individuals with autoimmune lymphoproliferative syndrome (ALPS) and dominantly interfere with apoptosis by an unknown mechanism. We show that local or global alterations in the structure of the cytoplasmic death domain from nine independent ALPS CD95 death-domain mutations result in a: failure to bind the FADD/MORT1 signaling protein. Despite heterozygosity for the abnormal allele, lymphocytes from ALPS patients showed markedly decreased FADD association and a loss of caspase recruitment and activation after CD95 crosslinking. These data suggest that intracytoplasmic CD95 mutations in ALPS impair apoptosis chiefly by disrupting death-domain interactions with the signaling protein FADD/MORT1.
引用
收藏
页码:4552 / 4557
页数:6
相关论文
共 39 条
[1]   TARGETED MUTATION IN THE FAS GENE CAUSES HYPERPLASIA IN PERIPHERAL LYMPHOID ORGANS AND LIVER [J].
ADACHI, M ;
SUEMATSU, S ;
KONDO, T ;
OGASAWARA, J ;
TANAKA, T ;
YOSHIDA, N ;
NAGATA, S .
NATURE GENETICS, 1995, 11 (03) :294-300
[2]   Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: A molecular and immunological analysis [J].
Bettinardi, A ;
Brugnoni, D ;
QuirosRoldan, E ;
Malagoli, A ;
LaGrutta, S ;
Correra, A ;
Notarangelo, LD .
BLOOD, 1997, 89 (03) :902-909
[3]   A NOVEL PROTEIN THAT INTERACTS WITH THE DEATH DOMAIN OF FAS/APO1 CONTAINS A SEQUENCE MOTIF RELATED TO THE DEATH DOMAIN [J].
BOLDIN, MP ;
VARFOLOMEEV, EE ;
PANCER, Z ;
METT, IL ;
CAMONIS, JH ;
WALLACH, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) :7795-7798
[4]   FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS [J].
CHINNAIYAN, AM ;
OROURKE, K ;
TEWARI, M ;
DIXIT, VM .
CELL, 1995, 81 (04) :505-512
[5]  
CHINNAIYAN MG, 1997, SEMIN IMMUNOL, V9, P69
[6]   MULTIPLE PATHWAYS ORIGINATE AT THE FAS/APO-1 (CD95) RECEPTOR - SEQUENTIAL INVOLVEMENT OF PHOSPHATIDYLCHOLINE-SPECIFIC PHOSPHOLIPASE-C AND ACIDIC SPHINGOMYELINASE IN THE PROPAGATION OF THE APOPTOTIC SIGNAL [J].
CIFONE, MG ;
RONCAIOLI, P ;
DEMARIA, R ;
CAMARDA, G ;
SANTONI, A ;
RUBERTI, G ;
TESTI, R .
EMBO JOURNAL, 1995, 14 (23) :5859-5868
[7]   Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity [J].
Drappa, J ;
Vaishnaw, AK ;
Sullivan, KE ;
Chu, JL ;
Elkon, KB .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (22) :1643-1649
[8]   The lymphoproliferation mutation in Fas locally unfolds the Fas death domain [J].
Eberstadt, M ;
Huang, BH ;
Olejniczak, ET ;
Fesik, SW .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (12) :983-985
[9]   DOMINANT INTERFERING FAS GENE-MUTATIONS IMPAIR APOPTOSIS IN A HUMAN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME [J].
FISHER, GH ;
ROSENBERG, FJ ;
STRAUS, SE ;
DALE, JK ;
MIDDELTON, LA ;
LIN, AY ;
STROBER, W ;
LENARDO, MJ ;
PUCK, JM .
CELL, 1995, 81 (06) :935-946
[10]   SELF-TOLERANCE CHECKPOINTS IN B-LYMPHOCYTE DEVELOPMENT [J].
GOODNOW, CC ;
CYSTER, JG ;
HARTLEY, SB ;
BELL, SE ;
COOKE, MP ;
HEALY, JI ;
AKKARAJU, S ;
RATHMELL, JC ;
POGUE, SL ;
SHOKAT, KP .
ADVANCES IN IMMUNOLOGY, VOL 59, 1995, 59 :279-368